Svetlana Nikic, PhD
Strategic advisor to diagnostics and biotechnology companies on the clinical adoption and market access of novel oncology diagnostics across Europe.
Over 18 years of experience in precision oncology, genomics and molecular diagnostics. Former leadership roles at Roche Diagnostics, Illumina and C2i Genomics.
Professional Overview
Svetlana Nikic is an international expert in precision oncology diagnostics with more than 18 years of experience across the global genomics and life sciences industry.
Throughout her career she has held roles at leading organisations including Roche Diagnostics and Illumina, working at the intersection of genomics, oncology diagnostics and healthcare innovation. Her experience spans industry strategy, clinical collaboration and the translation of emerging genomic technologies into real-world healthcare settings.
Today, through Precision Oncology Consulting, she advises diagnostics companies, biotechnology organisations and healthcare stakeholders on evidence generation, clinical adoption strategies and market access pathways for novel oncology diagnostics across Europe.
Her expertise includes comprehensive genomic profiling, whole-genome sequencing, liquid biopsy and minimal residual disease testing, with a particular focus on enabling the successful integration of novel diagnostic innovations into clinical practise.
Her work has involved collaboration with leading clinicians, laboratories and healthcare systems across Europe to accelerate the responsible adoption of precision oncology technologies.
Key Contribution
Advancing the clinical adoption of genomic medicine
She played a key role in supporting Swedish clinicians in launching one of the first national initiatives introducing whole-genome sequencing and whole-transcriptome analysis into routine clinical care for patients with acute leukaemia.
In parallel, she established an international network of oncology experts aimed at accelerating the clinical implementation of whole-genome sequencing and strengthening collaboration across institutions, laboratories and healthcare systems.
Industry Experience
Through senior roles across global diagnostics and genomics companies, Svetlana has contributed to the development, positioning and clinical adoption of precision oncology technologies across international healthcare systems. Her work has consistently focused on bridging the gap between technological innovation, clinical evidence generation and real-world healthcare implementation.
Areas of Expertise
Precision Oncology Strategy
Advising diagnostics, biotechnology and pharmaceutical companies on strategic positioning within the rapidly evolving precision oncology landscape.
Genomic Diagnostics & Sequencing
Experience in the development and clinical adoption of genomic technologies including whole-genome sequencing, transcriptomics and MRD testing in oncology.
Evidence Generation & Clinical Strategy
Supporting the design of clinical evidence strategies required to demonstrate clinical utility and enable adoption of innovative molecular diagnostics.
Market Access & Reimbursement
Developing market access strategies for oncology diagnostics across European healthcare systems and payer environments.
KOL Engagement & Scientific Collaboration
Building international expert networks and facilitating collaboration between clinicians, researchers and industry stakeholders.
Implementation of Genomic Medicine
Supporting the translation of genomic and AI-enabled diagnostics from research innovation into routine clinical practice.
Discuss your precision oncology strategy
Precision Oncology Consulting supports biotechnology, pharmaceutical, and diagnostics companies in navigating complex challenges in precision oncology, genomics, and molecular diagnostics.
